A former
The company, one of the nation’s largest kidney dialysis providers, and subsidiary, Bio-Medical Applications of California Inc., failed to persuade the US District Court for the District of Massachusetts that Jonathan Azurin’s lawsuit should be dismissed or paused until a ruling comes down in a separate proposed class action against the companies,Calderon v. Bio-Medical Applications of Mission Hills.
“Defendants have established parallelism ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
